| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.006 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.007 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |